Beth Israel Deaconess Medical Center Names Manuel Hidalgo, MD, PhD, Clinical Director of the Cancer Center and Chief of Hematology-Oncology

Get Permission

Manuel Hidalgo, MD, PhD

Manuel Hidalgo, MD, PhD, an oncologist whose work in experimental cancer therapy and tumor model development has led to key advances in the treatment of pancreatic cancer, has been named Director of the Leon V. & Marilyn L. Rosenberg Clinical Cancer Center and Chief of the Division of Hematology-Oncology at Beth Israel Deaconess Medical Center (BIDMC). Dr. Hidalgo will oversee all BIDMC clinical cancer programs when he joins the medical center in the coming months.

A native of Spain, Dr. Hidalgo comes to BIDMC from the Centro Nacional de Investigaciones Oncologicas (Spanish National Cancer Center), where he currently serves as Director of the Clinical Research Program and Vice Director of Translational Research. He holds faculty positions at University CEU San Pablo and Johns Hopkins University.

“I am honored to join BIDMC, which is a global leader in bringing together clinicians and scientists to promote excellence in cancer care,” said Dr. Hidalgo. “I share BIDMC’s philosophy that research and patient care inform and complement one another and that the skill and expertise of both disciplines will be required to win the fight against all types of cancer.”

Dr. Hidalgo is a founder of the Pancreatic Cancer Research Team, a private nonprofit cooperative group dedicated to rapid drug development in pancreatic cancer.

Dr. Hidalgo received his medical degree from the University of Navarra and his doctorate from the University Autonoma of Madrid. He completed a fellowship in anticancer drug development at the University of Texas Health Science Center in San Antonio. In 2001, Dr. Hidalgo joined Johns Hopkins as an Associate Professor and in 2003 became Codirector of its Gastrointestinal Cancer Program. Dr. Hidalgo joined the Spanish National Cancer Center in 2009.

“Dr. Hidalgo succeeds Lowell Schnipper, MD, an international leader in cancer care, who built and led from its inception BIDMC’s Hematology-Oncology Division,” said Mark Zeidel, MD, PhD, Chair of BIDMC’s Department of Medicine. “Through both his direct care of patients and his tireless advocacy for national patient-care initiatives, as well as his influential mentoring of ­BIDMC faculty, Dr. Schnipper has markedly improved the lives of thousands of cancer patients.”   ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.